Pain Management Device by Nd:YAG Laser, Hilthera 4.0
Negotiable Min Order Quantity Unit
- Required Quantity
-
- Place of Origin
- South Korea
- Payment Terms
- Negotiable
- Production method
- Negotiable
- Shipping / Lead Time
- Negotiable / Negotiable
REV-MED Inc.
South Korea
- Verified Certificate
-
15
| Product name | Pain Management Device by Nd:YAG Laser, Hilthera 4.0 | Certification | CE |
|---|---|---|---|
| Category |
Medical Consumables
Industry Laser Equipment & Parts Other Surgical Equipment |
Ingredients | - |
| Keyword | laser machine , laser treatment , osteoarthrosis , orthopedic therapy | Unit Size | - |
| Brand name | - | Unit Weigh | - |
| origin | South Korea | Stock | - |
| Supply type | - | HS code | - |
Product Information
Hilthera is the Pain Management Device using High Intensity Laser of Nd:YAG.
Advantages
First, the laser using ND-YAG Laser with 1064nm wavelength can penetrates deep into the skin
Second, Hilthera has the most powerful energy power (1,200 mJ), fastest pulse repetition rate (30Hz) and has the largest beam diameter (Ø8mm).
Third, no pain at all during the operation and you can find immediate effect with long lasting benefits
Indications
Tendinopathies, Muscle lesions, Osteochondral Lesions, Osteoarthrosis
- Product Info Attached File
- Verified Certificate
-
B2B Trade
| Price (FOB) | Negotiable | transportation | - |
|---|---|---|---|
| MOQ | Negotiable | Leadtime | Negotiable |
| Payment Options | Negotiable | Shipping time | Negotiable |
REV-MED Inc.
-
15
- President
- Edward Shin
- Address
- 464 Dunchon-daero,#306 Dream techno, Jungwon-gu, Seongnam-si, Gyeonggi-do, Korea
- Product Category
- Beauty & Personal Care,Other Machinery & Industry Equipment,Other Surgical Equipment
- Year Established
- 2009
- No. of Total Employees
- 1-50
- Company introduction
-
REV-MED has beenexporting to over 30 countries including Asia, EU, specializing in inventingand manufacturing Autologous Biological Systems and Pain Management MedicalDevice. Especially, we are the onlycompany registered in China and Japan as a class 3.
So far, alongwith 6 clinic papers, we have achieved over 10 patents in relation to systems,methods, and apparatuses for autologous biological therapeutics, including butnot limited to PRP and BMC therapy and technology.
- Main Product
_POWER_COL_TRA_2.jpg "Power Col Tra")
